Tag: Embrace HES

Instylla announces positive results from preclinical studies of Embrace™ Hydrogel Embolic System in hemorrhage models

BEDFORD, Mass., July 26, 2022 /PRNewswire/ — Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced two publications that evaluated the Embrace™ Hydrogel Embolic System (HES) in preclinical porcine hemorrhage models. In a Journal of Vascular […]